NXP Semi, F5 Networks down 4% each after earnings; Pfizer, BioNTech advance COVID vaccine candidate to ph2/3 trial Check out this evening's top movers from around Wall Street, compiled by The Fly.
UP AFTER EARNINGS
-
- Amkor Technology (AMKR) up 16.7%
- OneMain Holdings (OMF) up 13.9%
- Medpace (MEDP) up 13.2%
- Vocera (VCRA) up 10.8%
- TriNet Group (TNET) up 10.5%
- Comfort Systems (FIX) up 9.4%
- Intevac (IVAC) up 6.4%
- Aerojet Rocketdyne (AJRD) up 5.4%
- AGNC Investment (AGNC) up 2.9%
- Principal Financial (PFG) up 2.7%
ALSO HIGHER
-
- Spectrum Pharma (SPPI) up 68.8% after announcing it met pre-specified primary endpoint in ZENITH20 Phase 2 trial for poziotinib in NSCLC
- Lumos Pharma (LUMO) up 19.1% after selling Ervebo PRV to Merck for $60M
- Black Stone Minerals (BSM) up 11.6% after raising quarterly dividend by 88%
- Bausch Health (BHC) up 4.3% after disclosing 5.9% stake taken by Glenview
- BioNTech (BNTX) up 4.1%, Pfizer (PFE) up 1.6% after their joint BNT162 COVID-19 vaccine candidate entered ph.2/3 trial
- Prevail Therapeutics (PRVL) up 3.3% after issuing composition of matter patent from USPTO for PR006
- Chiasma (CHMA) up 2.7% after disclosing 48-week data on Chiasma Optimal trial of Mycapssa
DOWN AFTER EARNINGS
-
- NXP Semiconductors (NXPI) down 3.7%
- F5 Networks (FFIV) down 3.7%
- Hexcel (HXL) down 2.6%
- Simpson Manufacturing (SSD) down 2.3%
ALSO LOWER -
- CorMedicx (CRMD) down 13.3% after equity offering
- BioXcel Therapeutics (BTAI) down 3.2% after equity offering
Symbols:
AMKR OMF MEDP VCRA TNET FIX IVAC AJRD AGNC PFG SPPI LUMO BSM BHC BNTX PFE PRVL CHMA NXPI FFIV HXL SSD CRMD BTAI Keywords: fly intel, wall street, afterhours, movers, top stories, stocks, F5 Networks, NXP Semiconductors